Cite
APA Citation
Edenfield, W. J., Chung, K., O'Rourke, M., Cull, E., Martin, J., Bowers, H., Smith, W., & Gluck, W. L. (2021). a Phase II Study of Durvalumab in Combination with Tremelimumab in Patients with Rare Cancers. Oncologist, 26, e1499–e1507. http://access.bl.uk/ark:/81055/vdc_100139933539.0x000036